Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven G Deeks

Showing results (301-310 of 663) with videos related to

Pageof 67
Sort By:
Tropical Medicine & International Health : TM & IH|July 1, 2010
Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in AfricaElvin H Geng, David V Glidden, Nneka Emenyonu, et al.
AIDS (London, England)|December 13, 2002
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjectsPeter A Anton, Ronald T Mitsuyasu, Steven G Deeks, et al.
Lancet (London, England)|April 2, 2013
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsChristine Katlama, Steven G Deeks, Brigitte Autran, et al.
AIDS (London, England)|July 17, 2014
A closer look at hepatitis C clearance in HIV controllers: a responseAlice K Asher, Glenn-Milo Santos, Jennifer Evans, et al.
Blood|December 18, 2012
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infectionEdwin Leeansyah, Anupama Ganesh, Máire F Quigley, et al.
Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.
Plos One|March 4, 2014
Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and agingSulggi A Lee, Elizabeth Sinclair, Hiroyu Hatano, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIVMatthew S Durstenfeld, Michael J Peluso, Matthew A Spinelli, et al.
American Heart Journal|March 2, 2026
Rationale, design, and baseline characteristics of the Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection: EPIC-HIV Randomized Clinical TrialMatthew S Durstenfeld, Marta Levkova-Clark, Danny Li Ms, et al.
Plos One|August 3, 2016
Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral TherapySulggi A Lee, Peter Bacchetti, Nicolas Chomont, et al.
Pageof 67

Showing results (301-310 of 663) with videos related to

Sort By:
Pageof 67
Tropical Medicine & International Health : TM & IH|July 1, 2010
Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in AfricaElvin H Geng, David V Glidden, Nneka Emenyonu, et al.
AIDS (London, England)|December 13, 2002
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjectsPeter A Anton, Ronald T Mitsuyasu, Steven G Deeks, et al.
Lancet (London, England)|April 2, 2013
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirsChristine Katlama, Steven G Deeks, Brigitte Autran, et al.
AIDS (London, England)|July 17, 2014
A closer look at hepatitis C clearance in HIV controllers: a responseAlice K Asher, Glenn-Milo Santos, Jennifer Evans, et al.
Blood|December 18, 2012
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infectionEdwin Leeansyah, Anupama Ganesh, Máire F Quigley, et al.
Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.
Plos One|March 4, 2014
Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and agingSulggi A Lee, Elizabeth Sinclair, Hiroyu Hatano, et al.
Medrxiv : the Preprint Server for Health Sciences|May 19, 2023
Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIVMatthew S Durstenfeld, Michael J Peluso, Matthew A Spinelli, et al.
American Heart Journal|March 2, 2026
Rationale, design, and baseline characteristics of the Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection: EPIC-HIV Randomized Clinical TrialMatthew S Durstenfeld, Marta Levkova-Clark, Danny Li Ms, et al.
Plos One|August 3, 2016
Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral TherapySulggi A Lee, Peter Bacchetti, Nicolas Chomont, et al.
Pageof 67